Literature DB >> 11821244

Impact of preeclampsia and gestational hypertension on birth weight by gestational age.

Xu Xiong1, Nestor N Demianczuk, L Duncan Saunders, Fu-Lin Wang, William D Fraser.   

Abstract

The predominant etiologic theory of preeclampsia is that reduced uteroplacental perfusion is the unique pathogenic process in the development of preeclampsia. Decreased uteroplacental blood flow would result in lower birth weights. To date, no study has assessed the effect of preeclampsia on birth weight by gestational age. Thus, the authors conducted a retrospective cohort study based on 97,270 pregnancies that resulted in delivery between 1991 and 1996 at 35 hospitals in northern and central Alberta, Canada. Differences in mean birth weight between women with preeclampsia and normotensive women ranged from -547.5 g to 239.5 g for gestational age categories ranging from < or = 32 weeks to > or = 2 weeks. The birth weights were statistically significantly lower among mothers with preeclampsia who delivered at < or = 37 weeks, with an average difference of -352.5 g. However, the birth weights were not lower among preeclamptic mothers who delivered after 37 weeks (average difference of 49.0 g). In Alberta, 61.2% of preeclamptic patients gave birth after 37 weeks of gestation. The authors conclude that babies born to mothers with preeclampsia at term have fetal growth similar to that of babies born to normotensive mothers. This finding does not endorse the currently held theory that reduced uteroplacental perfusion is the unique pathophysiologic process in preeclampsia.

Entities:  

Mesh:

Year:  2002        PMID: 11821244     DOI: 10.1093/aje/155.3.203

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  71 in total

1.  Aspirin therapy in preeclampsia: more questions than answers.

Authors:  Bello Shaibu Oricha
Journal:  Croat Med J       Date:  2006-02       Impact factor: 1.351

2.  The endoplasmic reticulum stress of placental impoverishment.

Authors:  Christopher W G Redman
Journal:  Am J Pathol       Date:  2008-08       Impact factor: 4.307

3.  Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants?

Authors:  Kristin Palmsten; Soko Setoguchi; Andrea V Margulis; Amanda R Patrick; Sonia Hernández-Díaz
Journal:  Am J Epidemiol       Date:  2012-03-22       Impact factor: 4.897

4.  Relationship between maternal gestational hypertension and home blood pressure in 7-year-old children and their mothers: Tohoku Study of Child Development.

Authors:  Miki Hosaka; Kei Asayama; Jan A Staessen; Nozomi Tatsuta; Michihiro Satoh; Masahiro Kikuya; Takayoshi Ohkubo; Hiroshi Satoh; Yutaka Imai; Kunihiko Nakai
Journal:  Hypertens Res       Date:  2015-05-14       Impact factor: 3.872

5.  Evidence for distinct preterm and term phenotypes of preeclampsia.

Authors:  Julie K Phillips; Mary Janowiak; Gary J Badger; Ira M Bernstein
Journal:  J Matern Fetal Neonatal Med       Date:  2010-07

Review 6.  Evidence for Corpus Luteal and Endometrial Origins of Adverse Pregnancy Outcomes in Women Conceiving with or Without Assisted Reproduction.

Authors:  Kirk P Conrad
Journal:  Obstet Gynecol Clin North Am       Date:  2020-03       Impact factor: 2.844

7.  Glycogen phosphorylase isoenzyme BB plasma concentration is elevated in pregnancy and preterm preeclampsia.

Authors:  JoonHo Lee; Roberto Romero; Zhong Dong; Deug-Chan Lee; Yi Dong; Pooja Mittal; Tinnakorn Chaiworapongsa; Sonia S Hassan; Chong Jai Kim
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

Review 8.  First trimester screening for pre-eclampsia.

Authors:  Stefan C Kane
Journal:  Obstet Med       Date:  2016-05-14

9.  The impact of preeclampsia in pregnancy.

Authors:  Aferdita Manaj; Arben Rrugia; Nikita Manoku
Journal:  J Prenat Med       Date:  2011-01

10.  Biological indicators of the in-utero environment and their association with birth weight for gestational age.

Authors:  N M Talge; C Holzman; P K Senagore; M Klebanoff; R Fisher
Journal:  J Dev Orig Health Dis       Date:  2011-10       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.